Starling Oncology (STLNW) EBITDA Margin Growth (1y) (2022 - 2026)
Powered by 
Analysis
Starling Oncology (STLNW) EBITDA Margin Growth (1y) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.90 Bn | 11.21 Bn | 1.16 Bn | 38.00 |
| 2 | RadNet | 5.52 Bn | 4.79 Bn | 88.08 Mn | 14.00 |
| 3 | Fresenius Medical Care AG | 4.79 Bn | 4.09 Bn | 1.52 Bn | -713.00 |
| 4 | Concentra Group Holdings Parent | 4.28 Bn | 4.12 Bn | 192.10 Mn | 273.00 |
| 5 | Privia Health | 2.57 Bn | 2.16 Bn | - | 121.00 |
| 6 | Pediatrix Medical | 2.15 Bn | 1.74 Bn | - | -110.00 |
| 7 | Progyny | 2.12 Bn | 1.89 Bn | 89.30 Mn | 410.00 |
| 8 | Surgery Partners | 1.82 Bn | 1.61 Bn | 622.10 Mn | -149.00 |
| 9 | U S Physical Therapy | 1.17 Bn | 1.14 Bn | 41.94 Mn | -238.00 |
| 10 | Starling Oncology | 4.13 Mn | -36.96 Mn | 27.17 Mn | 633.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 633.00 |
| Mar 31, 2026 | 472.00 |
| Dec 31, 2025 | 675.00 |
| Sep 30, 2025 | 790.00 |
| Jun 30, 2025 | 735.00 |
| Mar 31, 2025 | 970.00 |
| Dec 31, 2024 | 591.00 |
| Sep 30, 2024 | 279.00 |
| Jun 30, 2024 | 203.00 |
| Mar 31, 2024 | 2,420.00 |
| Dec 31, 2023 | 1,759.00 |
| Sep 30, 2023 | 1,446.00 |
| Jun 30, 2023 | 1,158.00 |
| Mar 31, 2023 | -951.00 |
| Dec 31, 2022 | 4,310.00 |
| Sep 30, 2022 | -2,663.00 |
| Jun 30, 2022 | -2,756.00 |
| Mar 31, 2022 | -2,965.00 |